Press Releases
Addressing the growing demand for new treatments with cell lines
Despite advancements in cell line development (CLD) technologies, challenges remain due to the complex structure of each molecule. In this article, James Taylor, our senior CLD scientist, discusses how we navigate the complexities to meet intricate molecule specifications, maintain regulatory compliance, and promote sustainability.
Read more (45-47P)
Despite advancements in cell line development (CLD) technologies, challenges remain due to the complex structure of each molecule. In this article, James Taylor, our senior CLD scientist, discusses how we navigate the complexities to meet intricate molecule specifications, maintain regulatory compliance, and promote sustainability.
Read more (45-47P)